Chimeric antigen receptor T cell therapy reduces vaccine immunity, with many patients lacking seroprotection despite stable antibody levels.

Vaccines and other immune-based interventions are among the most effective strategies for preventing and controlling disease. However, their development is ...

Immune checkpoint inhibitors have reshaped cancer treatment over the past decade, but the same immune activation that shrinks tumors can also turn against healthy tissue, including the brain. A ...

University of York researchers have identified a protein called ESB2 that functions as a “molecular shredder” inside the ...

Study has shown that obesity impairs antibody durability through germinal centre dysfunction while enhancing lung-resident ...

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) show that active mitochondria ...

Massive hepatic necrosis (MHN) represents the most severe pathological form of acute liver failure (ALF), with high mortality ...

Researchers at BITS Pilani Hyderabad Campus develop experimental vaccine against Streptococcus pneumoniae, offering hope for ...

A new study from the Peter Doherty Institute for Infection and Immunity shows that seasonal influenza vaccination does more ...

Precigen (NASDAQ:PGEN) executives used a fireside chat hosted by H.C. Wainwright to outline the company’s transition into a commercial-stage organization following the FDA approval of Papzimeos, the ...